Is NuCana PLC halal to invest in?

According to Musaffa's Shariah screening methodology, NuCana PLC (NCNA) is currently classified as NOT HALAL as of March 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is NuCana PLC a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes NuCana PLC using these criteria to determine its compliance status.

Can Muslims buy shares of NuCana PLC?

Muslim investors may consider investing in NuCana PLC if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is NuCana PLC classified as NOT HALAL?

Musaffa determines the Shariah status of NuCana PLC by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for NuCana PLC updated?

The Shariah compliance status of NuCana PLC may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like NuCana PLC become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of NuCana PLC?

You can check the latest Shariah compliance status of NuCana PLC on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

NCNA Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: March 30, 2026

Report Source: 2025 Annual Report

NuCana PLC. Stock Analysis NCNA

United States Health Care Nano Cap Report: 2025 Annual

NuCana Plc is a clinical stage biopharmaceutical company. The firm is focused on developing treatment outcomes for patients with cancer by applying its ProTide technology. The firm's pipeline includes NUC-7738 and NUC-3373. NUC-7738 is an anti-cancer agent that disrupts Ribonucleic acid (RNA) polyadenylation, profoundly impacts gene expression in cancer cells and targets multiple aspects of the tumor microenvironment. NUC-7738 is in the Phase II part of a Phase I/II study which is evaluating NUC-7738 as a monotherapy in patients with advanced solid tumors and in combination with pembrolizumab in patients with melanoma. NUC-3373 is a chemical entity derived from the nucleoside analog 5-fluorouracil, a chemotherapy agent. NUC-3373 is being evaluated in a Phase Ib/II modular study (NuTide:303) of NUC-3373 in combination with the PD-1 inhibitor pembrolizumab for patients with advanced solid tumors and in combination with docetaxel for patients with lung cancer.

Key Statistics of NuCana PLC (NCNA)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$2.03$2.31

Today's Open

$2.03

Volume

130.35K

P/E Ratio (TTM)

52 Week Range

$1.33$40.00

Market Cap

9.20M

Avg. Volume

34.98K

Dividend Yield

Financial Metrics & Statements of NuCana PLC (NCNA)

FAQ's for NuCana PLC (NCNA)

According to Musaffa’s Shariah screening methodology, NuCana PLC (NCNA) is currently classified as NOT HALAL as of March 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.